Elmer Video

Clininal Study Reporting Guidelines


Randomized trials (CONSORT)
Observational studies (STROBE)
Systematic reviews (PRISMA)
Case reports (CARE)
Qualitative research (SRQR
Diagnostic / prognostic studies (STARD)
Quality improvement studies (SQUIRE)
Economic evaluations (CHEERS)  
Animal pre-clinical studies (ARRIVE)
Study protocols (SPIRIT)
Clinical practice guidelines (AGREE)


Publishing Policy

Elmer Press Publishing Policies, and Guidelines to follow, click for details......


Our journals are open access, which means all the contents of the journals are accessible freely to all viewers from every part of the world as long as they have internet accessibility, More...

Contact Us


Elmer Press Inc.
9225 Leslie Street, Suite 201
Richmond Hill
Ontario, L4B 3H6
Tel:  647-671-2629 (alternative email)

Journals in Web of Science-ESCI

Journals Permanent Archiving

All journals published by Elmer Press are archived in Portico, which provides permanent digital archiving for scholarly journals.

Follow Us

COVID-19 and Long-COVID Studies


Publishing News

• Aug 30, 2023

Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma
By Nathan Visweshwar et al. Journal of Hematology, Volume 12, Number 4, August 2023.

Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunological approaches the main anchor in the management of DLBCL, with or without chemotherapeutic agents.  Read More....


• Aug 27, 2023

Effects of Helicobacter pylori Infection on the Prognosis of Chronic Atrophic Gastritis by Inducing the Macrophage Polarization
By Chun Na Zhao et al. Gastroenterology Research, Volume 16, Number 4, August 2023.

The effects of Helicobacter pylori (H. pylori) infection on the prognosis of chronic atrophic gastritis (CAG) are still unclear. The aim of our study was to discuss the role of H. pylori infection on the prognosis of CAG by inducing the M1/M2 macrophage polarization.  Read More....


• Aug 22, 2023

Nanotechnology in the Horizon: The Introductory Editorial for Cellular and Molecular Medicine Research
By Consolato M. Sergi. Cellular and Molecular Medicine Research, Volume 1, Number 1, September 2023.

Nanotechnology is handling any substance on a near-atomic scale to yield new assemblies, constituents, and devices. This technology has gained momentum in the second decade of this century. New technology in molecular biology and quantum physics advancements has been a pillar in underpinning new platforms and discoveries.  Read More....


• Aug 17, 2023

High Expression of F-Box Protein 43 Is Associated With Poor Prognosis and Adjuvant Chemotherapy Resistance in Colorectal Cancer
By Junyu Liu et al. World Journal of Oncology, Volume 14, Number 4, August 2023.

The F-box protein 43 (FBXO43), also referred to as endogenous meiotic inhibitor 2 (EMI2), has been linked to the advancement of various types of cancer, such as hepatocellular carcinoma, breast cancer, cholangiocarcinoma, and gastric cancer. Nevertheless, the precise function of FBXO43 in colorectal cancer (CRC) remains unclear.  Read More....